The TCGA invasive breast cancer dataset had the largest patient set of RNA-seq data (primary breast cancers for 180 AAs and 745 Whites) was used to quantify distributions of AR expression across patient groups in order to calculate a suitable threshold to stratify the entire dataset/population as AR-positive or AR-negative categories, based on highest and lowest tertiles, exclusively. This evidence concerns the gene AR and breast carcinoma.